Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A P Venook

Showing results (11-20 of 36) with videos related to

Pageof 4
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1989
Activity of coumarin and cimetidine in metastatic renal cell carcinomaA P Venook, Y Davenport, A Tseng
Blood|September 1, 1987
Prophylactic heparin in APLA P Venook, M A Shuman, L Corash
The New England Journal of Medicine|May 20, 2000
Hepatic arterial infusion of chemotherapy for metastatic colorectal cancerA P Venook, B Althaus, R S Warren
Cancer|August 1, 1993
Gallium-avid thymic hyperplasia in an adult after chemotherapy for Hodgkin diseaseE J Small, A P Venook, L E Damon
Oncology (Williston Park, N.Y.)|March 1, 1988
Regional chemotherapy for colorectal cancer metastatic to the liverA P Venook, R J Stagg, B J Lewis
Annals of Internal Medicine|September 1, 1987
Pentoxifylline and aplastic anemiaR D Mass, A P Venook, C A Linker, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1989
Elevated plasma tamoxifen levels in a patient with liver obstructionM W DeGregorio, V J Wiebe, A P Venook, et al.
Annals of Internal Medicine|June 15, 1992
The Sweet syndrome during therapy with granulocyte colony-stimulating factorJ W Park, B Mehrotra, B O Barnett, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 3, 1998
Tamoxifen in liver disease: potential exacerbation of hepatic dysfunctionL C Floren, M F Hebert, A P Venook, et al.
British Journal of Cancer|July 7, 2005
Serum CA19-9 response as a surrogate for clinical outcome in patients receiving fixed-dose rate gemcitabine for advanced pancreatic cancerA H Ko, J Hwang, A P Venook, et al.
Pageof 4

Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1989
Activity of coumarin and cimetidine in metastatic renal cell carcinomaA P Venook, Y Davenport, A Tseng
Blood|September 1, 1987
Prophylactic heparin in APLA P Venook, M A Shuman, L Corash
The New England Journal of Medicine|May 20, 2000
Hepatic arterial infusion of chemotherapy for metastatic colorectal cancerA P Venook, B Althaus, R S Warren
Cancer|August 1, 1993
Gallium-avid thymic hyperplasia in an adult after chemotherapy for Hodgkin diseaseE J Small, A P Venook, L E Damon
Oncology (Williston Park, N.Y.)|March 1, 1988
Regional chemotherapy for colorectal cancer metastatic to the liverA P Venook, R J Stagg, B J Lewis
Annals of Internal Medicine|September 1, 1987
Pentoxifylline and aplastic anemiaR D Mass, A P Venook, C A Linker, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1989
Elevated plasma tamoxifen levels in a patient with liver obstructionM W DeGregorio, V J Wiebe, A P Venook, et al.
Annals of Internal Medicine|June 15, 1992
The Sweet syndrome during therapy with granulocyte colony-stimulating factorJ W Park, B Mehrotra, B O Barnett, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 3, 1998
Tamoxifen in liver disease: potential exacerbation of hepatic dysfunctionL C Floren, M F Hebert, A P Venook, et al.
British Journal of Cancer|July 7, 2005
Serum CA19-9 response as a surrogate for clinical outcome in patients receiving fixed-dose rate gemcitabine for advanced pancreatic cancerA H Ko, J Hwang, A P Venook, et al.
Pageof 4